Research Peptide Comparison
CJC-1295 without DAC 5mg and MOTS-c 40mg are both Research Peptides research peptides available from Neovia Peptides. This comparison highlights the key differences in specifications, pricing, and availability to help inform your research decisions.
CJC-1295 without DAC, also referenced in the literature as Modified GRF 1-29, is a 30-amino-acid growth hormone-releasing hormone (GHRH) analog stabilised against enzymatic degradation but without the albumin-binding DAC moiety. Its short half-life produces a pulsatile GH-release profile that more closely approximates endogenous somatotropic signalling, making it a frequent reference compound in GHRH receptor and pituitary-response studies.
Compared to MOTS-c 40mg, CJC-1295 without DAC 5mg is priced at £27.99 with 99%+ verified purity. Its CAS registry number is 863288-34-0. It has a molecular weight of 3367.97 g/mol.
CJC-1295 without DAC 5mg is available in single size and ships with a full Certificate of Analysis from Janoshik Analytical. At £37.01 less than MOTS-c 40mg, it is the more affordable option in this comparison.
MOTS-c is a mitochondrially-encoded 16-amino-acid peptide that translocates to the nucleus under metabolic stress and engages the AMPK pathway to coordinate cytoprotective and substrate-utilisation responses. It is a primary subject of mitokine research and of investigations into how mitochondrial-derived signals shape aging, insulin sensitivity, and exercise adaptation.
Compared to CJC-1295 without DAC 5mg, MOTS-c 40mg is priced at £65.00 with 99%+ verified purity. Its CAS registry number is 1627580-64-6. It has a molecular weight of 2174.68 g/mol.
MOTS-c 40mg is available in 10mg, 40mg and ships with a full Certificate of Analysis from Janoshik Analytical. It is priced £37.01 higher than CJC-1295 without DAC 5mg.
All products sold by Neovia Peptides are strictly for in-vitro research and laboratory use only. Not intended for human or veterinary use, food additives, drugs, or cosmetics. By purchasing from this website, you agree that you understand and accept these terms.
